Invitation to audiocast for Devyser’s Q4 report 2023

On Tuesday February 20 at 09:00 CET, Devyser Diagnostics AB will host an online presentation of its Q4 2023 report (which will have been published earlier on February 20 at 07.30 CET). The presentation will be held in English.  
  
Dial-in number to the teleconference and a conference ID will be received by registering on the link below:
https://conference.financialhearings.com/teleconference/?id=5003238  
  
The presentation will also be webcast and can be accessed from the following web address:  
https://ir.financialhearings.com/devyser-diagnostics-q4-report-2023  
 
Speakers: CEO Fredrik Alpsten, CFO Sabina Berlin and CCO Theis Kipling 

For more information, please contact:
Fredrik Alpsten, CEO 
Email: [email protected] 
Telephone: +46 70 667 31 06
 
Sabina Berlin, CFO 
Email: [email protected] 
Telephone: +46 739 51 95 02

About Devyser
Devyser develops, manufactures and sells diagnostic solutions and analysis services to clinical laboratories in more than 65 countries. Our products are used for advanced genetic testing in the hereditary disease, oncology and transplant fields, to enable targeted cancer treatment, the diagnosis of a large number of genetic diseases, and transplant patient follow-up. Devyser's products, and unique, patented solution requiring only one test tube, simplify genetic testing processes, improve sample throughput, minimize hands-on time and deliver rapid results. Our goal is for every patient to receive a correct diagnosis in the shortest possible time. Sustainability is a central part of our business and an important prerequisite for long term value creation.

Devyser was founded in 2004 and is based in Stockholm, Sweden with eight in-house sales offices in Europe and the US. The company also runs Devyser Genomic Laboratories, a CLIA certified laboratory in Atlanta, US. In 2022, Devyser's quality management system was certified according to the IVDR and a number of the company's products have since been certified according to the IVDR.

Devyser's shares are listed on the Nasdaq First North Premier Growth Market Stockholm (ticker: DVYSR). The company's Certified Adviser is Redeye AB. 

For more information, visit www.devyser.com.